GCTK (GlucoTrack) Tariff Resilience Score: 4/10 (As of Jul. 04, 2026)


GCTK GlucoTrack Inc GCTK
19 GF Score
Price $0.32
! 2 Warning Signs
View Full Analysis

What is GlucoTrack Tariff Resilience Score?

GlucoTrack GCTK -6.43% 19 Tariff Resilience Score is 4 as of Jul. 04, 2026. GuruFocus rates GCTK with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 837 Medical Devices & Instruments companies, GlucoTrack ranks better than 70.01% on this metric.

GlucoTrack has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

GlucoTrack has GlucoTrack relies on international suppliers for components, making it vulnerable to tariffs. Its limited pricing power and lack of alternative suppliers increase risk. However, its niche market may offer some protection from direct tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes GlucoTrack might have Average Resilient.

GlucoTrack  (NAS:GCTK) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

GlucoTrack Tariff Resilience Score Related Terms

GCTK vs YBGJ, RSCF, ECIA: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, GlucoTrack's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlucoTrack Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where GlucoTrack's Tariff Resilience Score falls into.


GCTK
19GF Score
GlucoTrack Inc GCTK
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
GlucoTrack (GCTK) has a Tariff Resilience Score of 4 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, GlucoTrack ranks #251 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 30%.
Is GlucoTrack's Tariff Resilience Score too high?
GlucoTrack's current Tariff Resilience Score is 4. Based on the distribution chart, GlucoTrack ranks #251 out of 837 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GlucoTrack has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does GlucoTrack's Tariff Resilience Score compare to YBGJ and RSCF?
According to the Medical Devices & Instruments industry distribution chart, GlucoTrack ranks #251 out of 837 companies for Tariff Resilience Score. This puts GlucoTrack in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. GlucoTrack's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlucoTrack stock overvalued right now?
GlucoTrack (GCTK) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4. GlucoTrack's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For GlucoTrack (GCTK), the current Tariff Resilience Score is 4 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlucoTrack Business Description

Address 301 Route 17 North, Suite 800, Rutherford, NJ, USA, 07070
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
19GF Score

Get the complete analysis for GCTK

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price